Effect of ambiguous hemochromatosis gene test results on physician utilization
- PMID: 22228247
- PMCID: PMC3440764
- DOI: 10.1097/MLR.0b013e318245a06e
Effect of ambiguous hemochromatosis gene test results on physician utilization
Abstract
Background: Genetic test results may be available to greater numbers of people through genetic screening projects and other means. The effects of widespread genetic testing and notification of genetic test results, particularly added costs through increased physician utilization, have not been clearly established.
Methods: A primary care-based cohort of 20,306 participants (Hemochromatosis and Iron Overload Study, Ontario site) were tested for the C282Y and H63D mutations of the HFE gene and for abnormal serum ferritin (SF) and transferrin saturation levels. The primary outcome variable was the total number of physician claims per patient after genetic test notification by mail. Multiple Poisson regression was used to adjust for age, sex, baseline SF, diagnoses of arthritis, diabetes, heart failure and impotence, self-rated health, and the number of claims during the 12 months before notification of results. The reference group had no HFE mutations (wild type) and normal transferrin saturation/SF values.
Results: Participants with an ambiguous hemochromatosis gene test and normal iron levels had statistically significantly higher average physician utilization of 3.0%. Participants with HFE mutations (excluding C282Y homozygotes) and elevated iron values showed a 6% increase in physician utilization.
Conclusions: The health effects, if any, of increased utilization in heterozygotes or those with mild ferritin elevations are unknown but are unlikely to be large at the population level. Ambiguous genetic test results are associated with increased physician service use and should be considered when assessing the complete societal costs of widespread genetic testing.
References
-
- Foltz AM, Kelsey JL. The annual pap test: A dubious policy success. Milbank Mem Fund Q Health Soc. 1978 Fall;56(4):426–62. - PubMed
-
- Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005 Apr 28;352(17):1769–78. - PubMed
-
- McLaren CE, Barton JC, Adams PC, Harris EL, Acton RT, Press N, et al. Hemochromatosis and iron overload screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci. 2003 Feb;325(2):53–62. - PubMed
-
- Vadaparampil ST, Miree CA, Wilson C, Jacobsen PB. Psychosocial and behavioral impact of genetic counseling and testing. Breast Dis. 2006–2007;27:97–108. - PubMed
-
- Anderson RT, Wenzel L, Walker AP, Ruggiero A, Acton RT, Hall MA, et al. Impact of hemochromatosis screening in patients with indeterminate results: The hemochromatosis and iron overload screening study. Genet Med. 2006 Nov;8(11):681–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
